Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiation Injuries | 6 | 2019 | 1178 | 1.540 |
Why?
|
| Radiosurgery | 10 | 2023 | 1309 | 1.190 |
Why?
|
| Cranial Irradiation | 4 | 2020 | 401 | 0.950 |
Why?
|
| Brain Neoplasms | 11 | 2023 | 8829 | 0.680 |
Why?
|
| Meningeal Neoplasms | 3 | 2024 | 1241 | 0.680 |
Why?
|
| Cholecystitis | 1 | 2017 | 182 | 0.550 |
Why?
|
| Gallbladder | 1 | 2017 | 301 | 0.520 |
Why?
|
| Glioblastoma | 5 | 2023 | 3456 | 0.450 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2023 | 1622 | 0.410 |
Why?
|
| Liver Neoplasms | 3 | 2017 | 4249 | 0.400 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 895 | 0.380 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 20774 | 0.360 |
Why?
|
| Bile Duct Neoplasms | 1 | 2014 | 567 | 0.330 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 516 | 0.330 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 947 | 0.310 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 1101 | 0.310 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1617 | 0.300 |
Why?
|
| Radiotherapy Dosage | 4 | 2023 | 2876 | 0.230 |
Why?
|
| Dacarbazine | 2 | 2015 | 567 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2211 | 0.210 |
Why?
|
| Heart | 1 | 2015 | 4462 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4029 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7901 | 0.200 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2015 | 627 | 0.190 |
Why?
|
| Neurilemmoma | 1 | 2024 | 547 | 0.160 |
Why?
|
| Lung | 2 | 2015 | 9826 | 0.150 |
Why?
|
| Tumor Burden | 3 | 2018 | 1905 | 0.140 |
Why?
|
| Cholelithiasis | 1 | 2017 | 411 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2017 | 876 | 0.130 |
Why?
|
| Patient Care | 1 | 2021 | 639 | 0.130 |
Why?
|
| Inhalation | 1 | 2015 | 143 | 0.130 |
Why?
|
| Meningioma | 1 | 2024 | 1209 | 0.130 |
Why?
|
| Endpoint Determination | 1 | 2017 | 600 | 0.120 |
Why?
|
| Prognosis | 5 | 2023 | 29010 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2023 | 2303 | 0.120 |
Why?
|
| Cysts | 1 | 2019 | 676 | 0.110 |
Why?
|
| Organs at Risk | 1 | 2015 | 346 | 0.110 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2014 | 295 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2021 | 1195 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 870 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2023 | 77098 | 0.090 |
Why?
|
| Humans | 27 | 2024 | 742088 | 0.090 |
Why?
|
| Female | 16 | 2023 | 379592 | 0.090 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2015 | 806 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1183 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 2002 | 0.080 |
Why?
|
| Erythroid Precursor Cells | 1 | 2008 | 218 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8621 | 0.070 |
Why?
|
| Aged | 10 | 2019 | 162944 | 0.070 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 1340 | 0.070 |
Why?
|
| Middle Aged | 11 | 2019 | 213127 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5249 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 39004 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 789 | 0.060 |
Why?
|
| Incidence | 1 | 2023 | 20928 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2020 | 53187 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 705 | 0.060 |
Why?
|
| Adenoma | 1 | 2014 | 2168 | 0.060 |
Why?
|
| Thalidomide | 1 | 2008 | 888 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2023 | 12344 | 0.050 |
Why?
|
| Progestins | 1 | 2024 | 303 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6722 | 0.050 |
Why?
|
| Male | 13 | 2021 | 349538 | 0.050 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 57683 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2019 | 62966 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 5979 | 0.050 |
Why?
|
| Genomics | 1 | 2017 | 5692 | 0.050 |
Why?
|
| Glioma | 1 | 2016 | 3388 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 7470 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8328 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6347 | 0.050 |
Why?
|
| Random Allocation | 1 | 2023 | 2425 | 0.040 |
Why?
|
| Steroids | 1 | 2024 | 931 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11039 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2008 | 1351 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6534 | 0.040 |
Why?
|
| Standard of Care | 1 | 2021 | 562 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 681 | 0.030 |
Why?
|
| Algorithms | 3 | 2022 | 13853 | 0.030 |
Why?
|
| Brain | 2 | 2022 | 26343 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 29717 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2010 | 11470 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23387 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 2466 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 35342 | 0.030 |
Why?
|
| Necrosis | 1 | 2018 | 1643 | 0.030 |
Why?
|
| Infection Control | 1 | 2021 | 962 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13019 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 369 | 0.030 |
Why?
|
| Adult | 6 | 2019 | 213712 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 3760 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 2014 | 254 | 0.030 |
Why?
|
| Genotype | 2 | 2017 | 12946 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20086 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1980 | 1357 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1653 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1269 | 0.030 |
Why?
|
| Acromegaly | 1 | 2014 | 347 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 2615 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 72145 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
| Stents | 1 | 2023 | 3276 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2014 | 850 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5062 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 74 | 0.020 |
Why?
|
| Anesthesiology | 1 | 1980 | 1043 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 137 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2017 | 1927 | 0.020 |
Why?
|
| Risk | 1 | 2021 | 9679 | 0.020 |
Why?
|
| Cause of Death | 1 | 2019 | 3571 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2023 | 5100 | 0.020 |
Why?
|
| Africa | 1 | 2010 | 670 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1771 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3661 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
| Radiology | 1 | 2021 | 2090 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2008 | 403 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1727 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 627 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11001 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 9941 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1400 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12773 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2633 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2890 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12242 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9185 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13256 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23320 | 0.010 |
Why?
|
| Suction | 1 | 1980 | 267 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 56350 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18355 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81045 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2008 | 3381 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13655 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 19223 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15056 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 9410 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 168561 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 35070 | 0.000 |
Why?
|
| Child | 1 | 2014 | 77478 | 0.000 |
Why?
|
| Adolescent | 1 | 2014 | 85649 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(110)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_